» Articles » PMID: 29033368

A DNA Vaccine Protects Human Immune Cells Against Zika Virus Infection in Humanized Mice

Overview
Journal EBioMedicine
Date 2017 Oct 17
PMID 29033368
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

A DNA vaccine encoding prM and E protein has been shown to induce protection against Zika virus (ZIKV) infection in mice and monkeys. However, its effectiveness in humans remains undefined. Moreover, identification of which immune cell types are specifically infected in humans is unclear. We show that human myeloid cells and B cells are primary targets of ZIKV in humanized mice. We also show that a DNA vaccine encoding full length prM and E protein protects humanized mice from ZIKV infection. Following administration of the DNA vaccine, humanized DRAG mice developed antibodies targeting ZIKV as measured by ELISA and neutralization assays. Moreover, following ZIKV challenge, vaccinated animals presented virtually no detectable virus in human cells and in serum, whereas unvaccinated animals displayed robust infection, as measured by qRT-PCR. Our results utilizing humanized mice show potential efficacy for a targeted DNA vaccine against ZIKV in humans.

Citing Articles

Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future.

Bello M, Alsaadi A, Naeem A, Almahboub S, Bosaeed M, Aljedani S Front Immunol. 2025; 15():1475886.

PMID: 39840044 PMC: 11747009. DOI: 10.3389/fimmu.2024.1475886.


Comparison of Three Chimeric Zika Vaccine Prototypes Developed on the Genetic Background of the Clinically Proven Live-Attenuated Japanese Encephalitis Vaccine SA-14-2.

Song B, Frank J, Yun S, Julander J, Mason J, Polejaeva I Int J Mol Sci. 2025; 26(1.

PMID: 39796052 PMC: 11720029. DOI: 10.3390/ijms26010195.


Reconstitution of human microglia and resident T cells in the brain of humanized DRAGA mice.

Ghosh Roy S, Karim A, Brumeanu T, Casares S Front Cell Infect Microbiol. 2024; 14:1367566.

PMID: 38983114 PMC: 11231403. DOI: 10.3389/fcimb.2024.1367566.


Development of a human glioblastoma model using humanized DRAG mice for immunotherapy.

Srivastava R, Labani-Motlagh A, Chen A, Bohorquez J, Qin B, Dodda M Antib Ther. 2023; 6(4):253-264.

PMID: 38075240 PMC: 10702851. DOI: 10.1093/abt/tbad021.


Human-Immune-System (HIS) humanized mouse model (DRAGA: HLA-A2.HLA-DR4.Rag1KO.IL-2RγcKO.NOD) for COVID-19.

Brumeanu T, Vir P, Karim A, Kar S, Benetiene D, Lok M Hum Vaccin Immunother. 2022; 18(5):2048622.

PMID: 35348437 PMC: 9225593. DOI: 10.1080/21645515.2022.2048622.


References
1.
Larocca R, Abbink P, Peron J, Zanotto P, Iampietro M, Badamchi-Zadeh A . Vaccine protection against Zika virus from Brazil. Nature. 2016; 536(7617):474-8. PMC: 5003703. DOI: 10.1038/nature18952. View

2.
Abbink P, Larocca R, De La Barrera R, Bricault C, Moseley E, Boyd M . Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science. 2016; 353(6304):1129-32. PMC: 5237380. DOI: 10.1126/science.aah6157. View

3.
DICK G, KITCHEN S, HADDOW A . Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952; 46(5):509-20. DOI: 10.1016/0035-9203(52)90042-4. View

4.
Tabata T, Petitt M, Puerta-Guardo H, Michlmayr D, Wang C, Fang-Hoover J . Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission. Cell Host Microbe. 2016; 20(2):155-66. PMC: 5257282. DOI: 10.1016/j.chom.2016.07.002. View

5.
Kublin J, Whitney J . Zika virus research models. Virus Res. 2017; 254:15-20. PMC: 5809325. DOI: 10.1016/j.virusres.2017.07.025. View